2020年美国三次COVID-19疫情高峰对院内心搏骤停生存率的影响
在Get-With-The-Guidelines®-Resuscitation登记中,纳入2020年3—12月的22,899例院内心搏骤停与2015—2019年同期的79,736例,用分层回归比较风险校正后的出院生存率。2020年三次高峰期间出院生存率均低于2015—2019年同期:高峰1调整OR 0.81(0.75-0.88)、高峰2调整OR 0.88(0.79-0.97)、高峰3调整OR 0.79(0.73-0.86);县月度COVID-19死亡率中度至高度的医院降低最明显。两个高峰后时期生存率与2015—2019年同期相似:高峰1后调整OR 0.93(0.83-1.04)、高峰2后调整OR 0.94(0.86-1.03),即使县COVID-19死亡率最高的医院也如此。
要点
- 2020年三次COVID-19高峰期间院内心搏骤停出院生存率均低于2015—2019年同期:高峰1调整OR 0.81(0.75-0.88)、高峰2调整OR 0.88(0.79-0.97)、高峰3调整OR 0.79(0.73-0.86)。
- 出院生存率下降在县月度COVID-19死亡率为中度至高度的医院最明显。
- 两个高峰后时期出院生存率与2015—2019年同期相似:高峰1后调整OR 0.93(0.83-1.04)、高峰2后调整OR 0.94(0.86-1.03)。
- 即使县COVID-19死亡率最高的医院,高峰后时期生存率也与2015—2019年同期相似。
适用人群与场景
- Get-With-The-Guidelines®-Resuscitation登记中2020年3—12月发生的22,899例院内心搏骤停,以及2015—2019年同期的79,736例。
诊断标准与关键阈值
- 县月度COVID-19死亡率按每100万居民分类:极低(0-10)、低(11-50)、中度(51-100)、高度(>100)。
研究设计与关键结果
- 研究类型为基于Get-With-The-Guidelines®-Resuscitation登记的分析,比较2020年与2015—2019年院内心搏骤停风险校正出院生存率。
- 2020年高峰1(3月至5月中旬)出院生存率低于2015—2019年同期,调整OR 0.81(0.75-0.88)。
- 2020年高峰2(7月至8月中旬)出院生存率低于2015—2019年同期,调整OR 0.88(0.79-0.97)。
- 2020年高峰3(10月中旬至12月)出院生存率低于2015—2019年同期,调整OR 0.79(0.73-0.86)。
- 出院生存率下降在县月度COVID-19死亡率为中度至高度的医院最明显。
- 高峰1后(5月中旬至6月)出院生存率2020年与2015—2019年同期相似,调整OR 0.93(0.83-1.04)。
- 高峰2后(8月中旬至10月中旬)出院生存率2020年与2015—2019年同期相似,调整OR 0.94(0.86-1.03)。
- 即使县COVID-19死亡率最高的医院,两个高峰后时期出院生存率也与2015—2019年同期相似。
证据类型、等级与局限
- 证据类型:基于Get-With-The-Guidelines®-Resuscitation登记的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Studies have reported lower survival for in-hospital cardiac arrest (IHCA) during the initial COVID-19 surge. Whether the pandemic reduced IHCA survival during subsequent surges and in areas with lower COVID-19 rates is unknown.
METHODS: Within Get-With-The-Guidelines®-Resuscitation, we identified 22,899 and 79,736 IHCAs during March to December in 2020 and 2015-2019, respectively. Using hierarchical regression, we compared risk-adjusted rates of survival to discharge in 2020 vs. 2015-19 during five COVID-19 periods: Surge 1 (March to mid-May), post-Surge 1 (mid-May to June), Surge 2 (July to mid-August), post-Surge 2 (mid-August to mid-October), and Surge 3 (mid-October to December). Monthly COVID-19 mortality rates for each hospital's county were categorized, per 1,000,000 residents, as very low (0-10), low (11-50), moderate (51-100), or high (>100).
RESULTS: During each COVID-19 surge period in 2020, rates of survival to discharge for IHCA were lower, as compared with the same period in 2015-2019: Surge 1: adjusted OR: 0.81 (0.75-0.88); Surge 2: adjusted OR: 0.88 (0.79-0.97), Surge 3: adjusted OR: 0.79 (0.73-0.86). Lower survival was most pronounced at hospitals located in counties with moderate to high monthly COVID-19 mortality rates. In contrast, during the two post-surge periods, survival rates were similar in 2020 vs. 2015-2019: post-Surge 1: adjusted OR 0.93 (0.83-1.04) and post-Surge 2: adjusted OR 0.94 (0.86-1.03), even at hospitals with the highest county-level COVID-19 mortality rates.
CONCLUSIONS: During the three COVID-19 surges in the U.S. during 2020, rates of survival to discharge for IHCA dropped substantially, especially in communities with moderate to high COVID-19 mortality rates.
参考来源
- Gupta K, Girotra S, Nallamothu BK, et al. Impact of the three COVID-19 surges in 2020 on in-hospital cardiac arrest survival in the United States. Resuscitation. 2021. PMID: 34838661. doi:10.1016/j.resuscitation.2021.11.025
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。